Aurobindo Pharma has target of Rs 117-118: Bhamre

Published on Tue, Jan 24, 2012 at 11:00 |  Source : CNBC-TV18

Updated at Tue, Jan 24, 2012 at 11:07  

16233 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr
Siddharth Bhamre, Angel Broking

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Aurobindo Pharma has target of Rs 117-118, says Siddharth Bhamre, Angel Broking.

Aurobindo Pharma has target of Rs 117-118:Bhamre told CNBC-TV18, "Aurobindo Pharma in pharma space in between showed significant run-up from lower levels in 3-4 trading sessions and after that has corrected. But ever since it is adding good amount of long positions, so we would be bullish over here. We have a target of Rs 117-118 at this point of time and one can fix a stop loss somewhere around Rs 95-96 and go long and trade with positive bias over there."

He further added, " Crompton Greaves may not be directly linked to L&T space but that is having a rub off effect of those drizzles and we are seeing good amount of long positions getting added in this counter. So that is also one of the stocks which we would like to trade with positive bias. We are not very bullish on metals, so probably would advice some profit booking over there in metal space."

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!